Last updated on May 2018

Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Hemodialysis | Cardiovascular Disease | Vitamin K Deficiency | Chronic Kidney Disease Stage 3 | Chronic Kidney Disease Stage 4 | Chronic Kidney Disease Stage 5
  • Age: Between 18 - 65 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Chronic Kidney Disease Stages 3 to 5
  • Receiving hemodialysis treatment for at least 3 months
  • Subject understands the study protocol and agrees to comply with it
  • Informed consent documents signed by subject

Exclusion Criteria:

  • Using vitamin supplements containing vitamin K
  • History of metabolic gastrointestinal diseases
  • Subjects presenting chronic degenerative and/or inflammatory diseases
  • Receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters (salicylates, antibiotics)
  • Subjects receiving corticosteroid
  • Use of anticoagulants
  • History of soy allergy
  • Have an unstable medical condition, such as having a life expectancy of less than 6 months in the judgment of the investigator
  • Known sensitivity, intolerance, or other adverse response to study drugs which would prevent compliance with study medication
  • Subjects who have participated in a clinical study more recently than one month before the current study

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.